The DOI matches its Crossref record; 278 of the 278 references it cites were found in a registry or an index.
Role of Notch and its oncogenic signaling crosstalk in breast cancer
Open accessAbstract
The Notch signaling plays a key role in cell differentiation, survival, and proliferation through diverse mechanisms. Notch signaling is also involved in vasculogenesis and angiogenesis. Moreover, Notch expression is regulated by hypoxia and inflammatory cytokines (IL-1, IL-6 and leptin). Entangled crosstalk between Notch and other developmental signaling (Hedgehog and Wnt), and signaling triggered by growth factors, estrogens and oncogenic kinases, could impact on Notch targeted genes. Thus, alterations of the Notch signaling can lead to a variety of disorders, including human malignancies. Notch signaling is activated by ligand binding, followed by ADAM/Tumor necrosis factor-α-converting enzyme (TACE) metalloprotease and γ-secretase cleavages that produce the Notch intracellular domain (NICD). Translocation of NICD into the nucleus induces the transcriptional activation of Notch target genes. The relationships between Notch deregulated signaling, cancer stem cells and the carcinogenesis process reinforced by Notch crosstalk with many oncogenic signaling pathways suggest that Notch signaling may be a critical drug target for breast and other cancers. Since current status of knowledge in this field changes quickly, our insight should be continuously revised. In this review, we will focus on recent advancements in identification of aberrant Notch signaling in breast cancer and the possible underlying mechanisms, including potential role of Notch in breast cancer stem cells, tumor angiogenesis, as well as its crosstalk with other oncogenic signaling pathways in breast cancer. We will also discuss the prognostic value of Notch proteins and therapeutic potential of targeting Notch signaling for cancer treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Items 201–278 of 278
Chen, C., Chang, Y., Liu, C., Chang, K., & Guo, I.-C. (2006) · Breast Cancer Research and Treatment · doi:10.1007/s10549-005-9139-y · Cited by 126
Notch2 Signaling Induces Apoptosis and Inhibits Human MDA-MB-231 Xenograft Growth
O’Neill, C. F., Urs, S., Cinelli, C. M., Lincoln, A., Nadeau, R. J., León, R., Toher, J. L., Mouta‐Bellum, C., Friesel, R. E., & Liaw, L. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.061029 · Cited by 126
Kiaris, H., Politi, K. A., Grimm, L. M., Szabolcs, M. J., Fisher, P. E., Efstratiadis, A., & Artavanis‐Tsakonas, S. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63333-0 · Cited by 123
Emerging roles of PDGF-D signaling pathway in tumor development and progression
Wang, Z. P., Ahmad, A., Li, Y., Kong, D., Azmi, A. S., Banerjee, S., & Sarkar, F. H. (2010) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2010.04.003 · Cited by 122
Leptin/HER2 crosstalk in breast cancer: in vitro study and preliminary in vivoanalysis
Fiorio, E., Mercanti, A., Terrasi, M., Micciolo, R., Remo, A., Auriemma, A., Molino, A., Parolin, V., Stefano, B. D., Bonetti, F., et al. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-305 · Cited by 122
Notch Signaling in Mammary Gland Tumorigenesis
Callahan, R., & Raafat, A. (2004) · Journal of mammary gland biology and neoplasia · doi:10.1023/a:1009512414430 · Cited by 120
A Wnt-ow of Opportunity: Targeting the Wnt/β-Catenin Pathway in Breast Cancer
Prosperi, J. R., & Goss, K. H. (2010) · Current Drug Targets · doi:10.2174/138945010792006780 · Cited by 119
Yao, J., Kim, T. W., Qin, J., Jiang, Z., Qian, Y., Xiao, H. Q., Lu, Y., Wen, Q., Gulen, M. F., Sizemore, N., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m609039200 · Cited by 118
A functional Notch–survivin gene signature in basal breast cancer
Lee, C. W., Simin, K. J., Liu, Q., Plescia, J., Guha, M., Khan, A. A., Hsieh, C., & Altieri, D. C. (2008) · Breast Cancer Research · doi:10.1186/bcr2200 · Cited by 118
Graziani, I., Eliasz, S., Marco, M. A. D., Chen, Y., Pass, H. I., May, R. M. D., Strack, P. R., Miele, L., & Bocchetta, M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0969 · Cited by 117
NOTCH and PI3K-AKT Pathways Intertwined
Gutiérrez, A., & Look, A. T. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.10.027 · Cited by 116
Molecular Dependence of Estrogen Receptor–Negative Breast Cancer on a Notch-Survivin Signaling Axis
Lee, C. W., Raskett, C. M., Prudovsky, I. A., & Altieri, D. C. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6673 · Cited by 115
Signaling Through RAS-RAF-MEK-ERK: from Basics to Bedside
Zebisch, A., Czernilofsky, A. P., Kéri, G., Smigelskaite, J., Sill, H., & Troppmair, J. (2007) · Current Medicinal Chemistry · doi:10.2174/092986707780059670 · Cited by 112
Heath, E., Tahri, D., Andermarcher, E., Schofield, P. N., Fleming, S., & Boulter, C. A. (2008) · BMC Developmental Biology · doi:10.1186/1471-213x-8-18 · Cited by 110
Soriano, J. V., Uyttendaele, H., Kitajewski, J., & Montesano, R. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000601)86:5<652::aid-ijc8>3.0.co;2-v · Cited by 106
Cancer Stem Cells: How can we Target them?
Ischenko, I., Seeliger, H., Schaffer, M., Jauch, K., & Bruns, C. J. (2008) · Current Medicinal Chemistry · doi:10.2174/092986708786848541 · Cited by 104
Wickenden, J. A., & Watson, C. J. (2010) · Breast Cancer Research · doi:10.1186/bcr2558 · Cited by 102
Notch3: from subtle structural differences to functional diversity
Bellavia, D., Checquolo, S., Campese, A. F., Felli, M. P., Gulino, A., & Screpanti, I. (2008) · Oncogene · doi:10.1038/onc.2008.230 · Cited by 99
Leptin regulation of proangiogenic molecules in benign and cancerous endometrial cells
Cariño, C., Olawaiye, A. B., Cherfils, S., Serikawa, T., Lynch, M. P., Rueda, B. R., & González, R. R. (2008) · International Journal of Cancer · doi:10.1002/ijc.23887 · Cited by 98
Kindler, T., Cornejo, M., Scholl, C., Liu, J., Leeman, D. S., Haydu, J. E., Fröhling, S., Lee, B. H., & Gilliland, D. G. (2008) · Blood · doi:10.1182/blood-2008-03-147587 · Cited by 97
Inhibition of angiogenesis and tumor growth by β and γ-secretase inhibitors
Paris, D., Quadros, A., Patel, N. S., DelleDonne, A., Humphrey, J., & MULLAN, M. J. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.02.050 · Cited by 95
Activation of Notch Signaling in a Xenograft Model of Brain Metastasis
Nam, D., Jeon, H.-M., Kim, S., Kim, M., Lee, Y.-J., Lee, M. S., Kim, H., Joo, K. M., Lee, D., Price, J. E., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4039 · Cited by 95
The proinflammatory transcription factor NFκB: a potential target for novel therapeutical strategies
Renard, P., & Raes, M. J. (1999) · Cell Biology and Toxicology · doi:10.1023/a:1007652414175 · Cited by 94
IL‐1 family in breast cancer: Potential interplay with leptin and other adipocytokines
Perrier, S., Caldefie‐Chezet, F., & Vasson, M. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.12.030 · Cited by 93
Notch1 Signaling and Regulatory T Cell Function
Asano, N., Watanabe, T., Kitani, A., Fuss, I. J., & Strober, W. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.5.2796 · Cited by 92
Albig, A. R., Becenti, D. J., Roy, T. G., & Schiemann, W. P. (2008) · Microvascular Research · doi:10.1016/j.mvr.2008.01.001 · Cited by 92
Efferson, C. L., Winkelmann, C. T., Ware, C. M., Sullivan, T., Giampaoli, S., Tammam, J. G., Patel, S. B., Mesiti, G., Reilly, J. F., Gibson, R. E., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3114 · Cited by 89
Inhibition of γ-secretase induces G2/M arrest and triggers apoptosis in breast cancer cells
Rasul, S., Balasubramanian, R., Filipović, A., Slade, M. J., Yagüe, E., & Coombes, R. C. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605034 · Cited by 88
Notch3 cooperates with the EGFR pathway to modulate apoptosis through the induction of bim
Konishi, J. S., Fu, Y., Chen, X., Vo, H., Carbone, D. P., & Dang, T. P. (2009) · Oncogene · doi:10.1038/onc.2009.366 · Cited by 86
The upgraded role of HER3 and HER4 receptors in breast cancer
Koutras, A. K., Fountzilas, G., Kalogeras, K. T., Starakis, I., Iconomou, G., & Kalofonos, H. P. (2009) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2009.04.011 · Cited by 86
Identifying estrogen receptor target genes
Welboren, W.-J., Stunnenberg, H. G., Sweep, F. C. G. J., & Span, P. N. (2007) · Molecular Oncology · doi:10.1016/j.molonc.2007.04.001 · Cited by 85
Efstratiadis, A., Szabolcs, M. J., & Klinakis, A. (2007) · Cell Cycle · doi:10.4161/cc.6.4.3838 · Cited by 84
Anti-EGFR Therapy: Mechanism and Advances in Clinical Efficacy in Breast Cancer
Flynn, J. F., Wong, C. S. F., & WU, J. M. (2009) · Journal of Oncology · doi:10.1155/2009/526963 · Cited by 81
Endogenous Hormones and Risk of Breast Cancer in Postmenopausal Women
Hankinson, S. E. (2006) · Breast Disease · doi:10.3233/bd-2006-24102 · Cited by 79
Pratt, M. A. C., Tibbo, E., Robertson, S., Jansson, D., Hurst, K., Perez‐Iratxeta, C., Lau, R., & Niu, M. Y. (2009) · Oncogene · doi:10.1038/onc.2009.131 · Cited by 79
Dong, Y., Li, A., Wang, J., Weber, J. D., & Michel, L. S. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0173 · Cited by 79
Noh, W. C., Kim, Y. H., Kim, M. S., Koh, J. S., Kim, H., Moon, N. M., & Paik, N.-S. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9746-x · Cited by 79
Interleukin-1α Promotes Tumor Growth and Cachexia in MCF-7 Xenograft Model of Breast Cancer
Kumar, S., Kishimoto, H., Chua, H. L., Badve, S., Miller, K. D., Bigsby, R. M., & Nakshatri, H. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63608-5 · Cited by 78
Cellular Notch responsiveness is defined by phosphoinositide 3-kinase-dependent signals
McKenzie, G. J., Ward, G. A., Stallwood, Y., Briend, E., Papadia, S., Lennard, A. C., Turner, M., CHAMPION, B. R., & Hardingham, G. E. (2006) · BMC Cell Biology · doi:10.1186/1471-2121-7-10 · Cited by 78
Effects of Recombinant Erythropoietin on Breast Cancer-Initiating Cells
Phillips, T. M., Kim, K., Vlashi, E., McBride, W. H., & Pajonk, F. (2007) · Neoplasia · doi:10.1593/neo.07694 · Cited by 75
Rennstam, K., McMichael, N., Berglund, P., Honeth, G., Hegardt, C., Rydén, L., Luts, L., Bendahl, P., & Hedenfalk, I. A. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0568-x · Cited by 75
Activated Notch1 interacts with p53 to inhibit its phosphorylation and transactivation
Kim, S. B., Chae, G. W., Lee, J., Park, J., Tak, H., Chung, J. H., Park, T. G., Ahn, J. K., & Joe, C. O. (2006) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402083 · Cited by 74
Hasson, P., & Paroush, Z. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603019 · Cited by 74
Wnt signaling in breast organogenesis
Boras-Granic, K., & Wysolmerski, J. J. (2008) · Organogenesis · doi:10.4161/org.4.2.5858 · Cited by 74
Seymour, L., & Bezwoda, W. R. (1994) · Breast Cancer Research and Treatment · doi:10.1007/bf00665774 · Cited by 73
The oncogenic roles of Notch1 in astrocytic gliomas in vitro and in vivo
Xu, P., Qiu, M., Zhang, Z., Kang, C., Jiang, R., Jia, Z., Wang, G., Jiang, H., & Pu, P. (2009) · Journal of Neuro-Oncology · doi:10.1007/s11060-009-0007-1 · Cited by 72
Zhao, X., Malhotra, G. K., Lele, S. M., Lele, M. S., West, W. W., Eudy, J. D., Band, H., & Band, V. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1009030107 · Cited by 72
NUMB is a break of WNT - Notch signaling cycle
Katoh, M., & Katoh, M. (2006) · International Journal of Molecular Medicine · doi:10.3892/ijmm.18.3.517 · Cited by 71
The role of PDGF in radiation oncology
Li, M., Jendrossek, V., & Belka, C. (2007) · Radiation Oncology · doi:10.1186/1748-717x-2-5 · Cited by 69
Ling, H., Sylvestre, J.-R., & Jolicoeur, P. (2010) · Oncogene · doi:10.1038/onc.2010.186 · Cited by 69
RAS in cellular transformation and senescence
DeNicola, G. M., & Tuveson, D. A. (2009) · European Journal of Cancer · doi:10.1016/s0959-8049(09)70036-x · Cited by 69
Leptin regulation of aromatase activity in adipose stromal cells from regularly cycling women.
Magoffin, D. A., Weitsman, S., Sk, A., & Jakimiuk, A. J. (1999) · PubMed · Cited by 67
Pharmacogenomics of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors
Jimeno, A., & Hidalgo, M. M. (2006) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2006.08.008 · Cited by 64
Notch1 regulates the functional contribution of RhoC to cervical carcinoma progression
Srivastava, S., Ramdass, B., Nagarajan, S., Rehman, M., Mukherjee, G., & Krishna, S. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605451 · Cited by 62
Veenendaal, L. M., Kranenburg, O., Smakman, N., Klomp, A., Rinkes, I. H. M. B., & van Diest, P. J. (2008) · Analytical Cellular Pathology · doi:10.1155/2008/839076 · Cited by 61
Fu, Y., Edvardsen, H., Kaushiva, A., Arhancet, J. P., Howe, T. M., Kohaar, I., Porter-Gill, P. A., Shah, A., Landmark‐Høyvik, H., Fosså, S. D., et al. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-113 · Cited by 61
Wang, M., Wu, L., Wang, L. Q., & Xin, X. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.01.103 · Cited by 60
NF- B Activation by Tumor Necrosis Factor and Interleukin-1Preprint
Cao, Z., Tanaka, M., Régnier, C. H., Rothe, M., Yamit-Hezi, A., Woronicz, J. D., FUENTES, M. E., Durnin, M., Dalrymple, S. A., & Goeddel, D. V. (1999) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1999.64.473 · Cited by 56
Activation of Wnt/β‐catenin/Tcf signaling in mouse skin carcinogenesis
Bhatia, N., & Spiegelman, V. S. (2005) · Molecular Carcinogenesis · doi:10.1002/mc.20077 · Cited by 55
Notch signaling and its role in breast cancer
Wu, F. (2007) · Frontiers in bioscience · doi:10.2741/2394 · Cited by 53
Leptin as a potential therapeutic target for breast cancer prevention and treatment
Ray, A., & Cleary, M. P. (2010) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728221003716466 · Cited by 50
Müller, P., Kietz, S., Gustafsson, J.-Α., & Ström, A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200340200 · Cited by 49
Ström, A., Arai, N., Leers, J., & Gustafsson, J.-Α. (2000) · Oncogene · doi:10.1038/sj.onc.1203990 · Cited by 48
Lee, J. H., Suk, J., Park, J., Kim, S. B., Kwak, S. S., Kim, J. W., Lee, C. H., Byun, B., Ahn, J. K., & Joe, C. O. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0191 · Cited by 47
Transactivation of erbB2 by short and long isoforms of leptin receptors
Eisenberg‐Lerner, A., Biener, E., Charlier, M., Krishnan, R. V., Djiane, J., Herman, B. A., & Gertler, A. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.03.089 · Cited by 46
Beisner, J., Buck, M. B., Fritz, P., Dippon, J., Schwab, M. G., Brauch, H. B., Zugmaier, G., Pfizenmaier, K., & Knabbe, C. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0634 · Cited by 42
A role for Numb in p53 stabilization
Carter, S., & Vousden, K. H. (2008) · Genome biology · doi:10.1186/gb-2008-9-5-221 · Cited by 42
Cancer Therapy By Targeting Hypoxia-Inducible Factor-1
Li, Y., & Ye, D. (2010) · Current Cancer Drug Targets · doi:10.2174/156800910793605857 · Cited by 41
Watters, J., Cheng, C., Majumder, P. K., Wang, R., Yalavarthi, S., Meeske, C., Kong, L., Sun, W., Lin, J., Heyer, J., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1544 · Cited by 40
Tumour-related microRNAs functions in Caenorhabditis elegans
Jannot, G., & Simard, M. J. (2006) · Oncogene · doi:10.1038/sj.onc.1209921 · Cited by 40
Cross-Talk Between Notch and EGFR Signaling in Human Breast Cancer Cells
Dai, J., Ma, D., Zang, S., Guo, D., Qu, X., Ye, J., & Ji, C. (2009) · Cancer Investigation · doi:10.1080/07357900802563036 · Cited by 36
Notch Signaling in Embryonic and Adult Myelopoiesis
Schwanbeck, R., Schroeder, T., Henning, K., Kohlhof, H., Rieber, N. P., Erfurth, M., & Just, U. (2008) · Cells Tissues Organs · doi:10.1159/000113531 · Cited by 32
Comparative genomics on Sonic Hedgehog orthologs
Katoh, Y., & Katoh, M. (2005) · Oncology Reports · doi:10.3892/or.14.4.1087 · Cited by 30
Gustafson, T. L., Wellberg, E. A., Laffin, B., Schilling, L., Metz, R. P., Zahnow, C. A., & Porter, W. W. (2009) · Oncogene · doi:10.1038/onc.2008.497 · Cited by 29
Hedgehog Signaling in the Normal and Neoplastic Mammary Gland
Visbal, A. P., & Lewis, M. T. (2010) · Current Drug Targets · doi:10.2174/138945010792006753 · Cited by 26
Zhang, H., Ye, Y., Bai, Z., et al. (2008) · Digestive Diseases and Sciences · doi:10.1007/s10620-007-0139-0 · Cited by 25
Solomon, A., Mian, Y. A., Ortega-Cava, C. F., Liu, V. W. T., Gurumurthy, C. B., Naramura, M., Band, V., & Band, H. (2008) · Developmental Biology · doi:10.1016/j.ydbio.2007.12.046 · Cited by 23
Fong, J. E., Nihouannen, D. L., & Komarova, S. V. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.114496 · Cited by 15
Cited by
Mitchell, S., Vargas, J., & Hoffmann, A. (2016) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1331 · Cited by 1,029
Sustained proliferation in cancer: Mechanisms and novel therapeutic targets
Feitelson, M. A., Arzumanyan, A., Kulathinal, R. J., Blain, S. W., Holcombe, R. F., Mahajna, J., Marino, M., Martinez-Chantar, M. L., Nawroth, R., Sanchez-Garcia, I., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.02.006 · Cited by 778
Self-citationThe Notch signalling system: recent insights into the complexity of a conserved pathway
Guruharsha, K. G., Kankel, M. W., & Artavanis-Tsakonas, S. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3272 · Cited by 705
Constitutive activation of STAT 3 in breast cancer cells: A review
Banerjee, K., & Resat, H. (2016) · International Journal of Cancer · doi:10.1002/ijc.29923 · Cited by 611
Notch signaling pathway in cancer: from mechanistic insights to targeted therapies
Shi, Q., Xue, C., Zeng, Y., Yuan, X., Chu, Q., Jiang, S., Wang, J., Zhang, Y., Zhu, D., & Li, L. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01828-x · Cited by 401
Metadata
- Authors
- Guo, S., Liu, M., & Gonzalez-Perez, R. R.
- Venue
- Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
- Publisher
- Elsevier BV
- Published
- 2011-04
- Volume
- 1815
- Issue
- 2
- Pages
- 197-213
- ISSN
- 0304-419X (ISSN-L)
- OpenAlex
- W2133977960
- Cited by
- 260
- References
- 278
- FWCI
- 6.85
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.